Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI)
NCT00951210 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2015-05-27
Summary
The purpose of this study is to determine the safety of PLX-PAD, Intra-muscular injections for the treatment of CLI patients.
Conditions
- Peripheral Artery Disease
- Peripheral Vascular Disease
- Critical Limb Ischemia
Interventions
- BIOLOGICAL
-
PLX-PAD
IM injection
Sponsors & Collaborators
-
Pluristem Ltd.
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 40 Years
- Max Age
- 81 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-08-31
- Primary Completion
- 2011-01-31
- Completion
- 2011-10-31
Countries
- United States
Study Locations
More Related Trials
-
Treatment of Intermittent Claudication by G-CSF-mobilized PB-MNC
NCT03683628 ·Status: UNKNOWN ·Phase: NA
-
Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19
NCT04389450 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI)
NCT02501018 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Evolocumab in Patients With Critical Limb Ischemia (Evol-CLI)
NCT04306471 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions
NCT00566657 ·Status: COMPLETED ·Phase: PHASE3
-
Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention
NCT01599078 ·Status: UNKNOWN ·Phase: NA
-
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
NCT07318610 ·Status: RECRUITING ·Phase: PHASE3
-
Cilostazol After Lower Extremity Arterial Revascularization Trial
NCT02374957 ·Status: TERMINATED ·Phase: PHASE4
-
Treatment of PAD by Platelet Lysate for Therapeutic Angiogenesis
NCT02941419 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease
NCT02544204 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Feasibility Study of the Shockwave Lithoplasty System
NCT01577888 ·Status: COMPLETED ·Phase: NA
-
Switch to Ticagrelor in Critical Limb Ischemia Anti-platelet Study
NCT02091921 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Paclitaxel on Intimal Hyperplasia
NCT01454778 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography)
NCT06204237 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Assess the Safety and Effectiveness of Once Daily PMR Compared to Twice Daily Pletaal® in Patients With Intermittent Claudication
NCT06886620 ·Status: TERMINATED ·Phase: PHASE3
-
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
NCT03304821 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Allogenic Platelet Lysate in Peripheral Arterial Disease (PAD)
NCT03297814 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease
NCT00059644 ·Status: TERMINATED ·Phase: PHASE3
-
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
NCT01178320 ·Status: COMPLETED
-
Evaluation of Cilostazol in Combination With L-Carnitine
NCT00822172 ·Status: COMPLETED ·Phase: PHASE4
-
A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients
NCT01499420 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in Patients With Mixed Dyslipidemia
NCT06497127 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
NCT01131013 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Oral L-Citrulline in Patients Taking Simvastatin With Peripheral Arterial Disease
NCT00351286 ·Status: UNKNOWN ·Phase: PHASE2
-
Trial to Investigate the Effect of Dapagliflozin on Ischemia Reperfusion Induced Endothelial Dysfunction
NCT05217654 ·Status: UNKNOWN ·Phase: PHASE1